[29V02-pm] その他/合成医薬品/医薬品設計③

Mon. Mar 29, 2021 3:03 PM - 4:39 PM [Room V02] Oral Presentation 2 (Online)

座長：加来田博貴（岡山大院医歯薬）、松野研司（工学院大先進工学）

+Add all to schedule

3:03 PM - 3:15 PM

[29V02-pm09S] Development of high-affinity antibody-binding peptide applicable to site-specific antibody modification

○Rento Osawa¹, Kyohei Muguruma¹, Akane Fukuda¹, Konomi Fujita¹, Naoto Ishikawa², Akihiro Taguchi¹, Kentaro Takayama¹, Atsuhiko Taniguchi¹, Yuji Ito², Yoshio Hayashi¹ (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Grad. Sch. Sci. Eng., Kagoshima Univ.)

3:15 PM - 3:27 PM

[29V02-pm10] Synthesis and mode of action studies of α-substituted phenyl styryl ketone derivatives for anti-castration resistant prostate cancer.

○Yohei Saito¹, Atsushi Mizokami¹, Kouji Izumi¹, Renato Naito¹, Masuo Goto², Kyoko Nakagawa-Goto^1,2 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ., 2. Univ. North Carolina)

3:27 PM - 3:39 PM

[29V02-pm11S] Development of Peptide Alkaloid-type Compound Library Based on Brefeldin A

○Yuki Sato¹, Takehiro Nishimura¹, Kosuke Shiga¹, Akihiro Sugawara¹, Haruhisa Kikuchi¹ (1. Grad. Sch. Pharm. Sci., Tohoku Univ.)

3:39 PM - 3:51 PM

[29V02-pm12S] Development of cyclic RGD-functionalized closo-dodecaborate albumin conjugates as integrin targeting boron carriers for neutron capture therapy

○Kai Nishimura^1,2, Kazuki Kawai^1,2, Satoshi Okada¹, Shinichi Satou^3,1, Minoru Suzuki⁴, Takushi Takada⁴, Hiroyuki Nakamura¹ (1. CLS, Tokyo Tech., 2. Sch. Life Sci. Tech., Tokyo Tech., 3. FRIS., Tohoku Uni., 4. KUR.)

3:51 PM - 4:03 PM

[29V02-pm13S] Development of ¹⁰B-boron cluster-containing amino acid derivatives for BNCT

○Akari Matsushita¹, Mieko Tsuji¹, Tasuku Hirayama¹, Hideko Nagasawa¹ (1. Gifu Pharm. Univ.)

4:03 PM - 4:15 PM

[29V02-pm14S] The extensive 3D chemical space search with carborane-based molecules for PPI regulator discovery

○Yasunobu Asawa^1,2, Atsushi Yoshimori³, Kentaro Yamada⁴, Hiroyuki Kouji^5,6, Hiroyuki Nakamura¹ (1. Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Tech., 2. School of Life Science and Technology, Tokyo Tech., 3. Institute for Theoretical Medicine, Inc., 4. Faculty of Agriculture, Miyazaki University, 5. Faculty of Medicine, Oita Univ., 6. Oita University Institute of Advanced Medicine, Inc.)

4:15 PM - 4:27 PM

[29V02-pm15S] Synthesis and biological evaluation of trisubstituted meta-carborane library compounds for PPI inhibitors

○Saki Hatsuzawa¹, Yasunobu Asawa^2,3, Atsushi Yoshimori⁴, Kentaro Yamada^4,5, Hiroyuki Kouji^6,7, Yasuhiro Mazaki¹, Hiroyuki Nakamura² (1. School of Science, Kitasato university, 2. Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 3. School of Life Science and Technology, Tokyo Institute of Technology, 4. Institute for Theoretical Medicine, Inc., 5. Faculty of Agriculture, Miyazaki University, 6. Faculty of Medicine, Oita University, 7. Oita University Institute of Advanced Medicine, Inc.)

4:27 PM - 4:39 PM

[29V02-pm16S] Synthetic study of stable bioisostere of antiinflammatory lipid mediator RvE3

○Shota Arai¹, Koichi Fujiwara¹, Hayato Fukuda¹, Mizuki Watanabe¹, Haruka Aoki², Masakiyo Yatomi², Yasuhiko Koga², Tsugumichi Saito², Takeshi Hisada², Satoshi Shuto¹ (1. Fac. Pharm. Sci., Hokkaido Univ., 2. Grad. Sch. Med., Gunma Univ.)

Session information